Welcome to ProAxsis

ProAxsis is developing a range of products for the capture, detection and measurement of active protease biomarkers of disease, using its patented ProteaseTag® technology.

ProAxsis specialises in four key areas of business:-

 

 

 

 

 

 

     
     

News

ProAxsis appoints first distributor for NE Immunoassay
ProAxsis today announces that the company has appointed Diagenics Limited as the distributor for its Pr...
ProAxsis signs partnership with a large US based biotechnology company
ProAxsis Ltd today announces that the company has signed a partnership agreement to develop activity-ba...
ProAxsis abstracts at 2017 European Respiratory Society Conference
ProAxsis will be presenting further data on its ProteaseTag® technology, at the European Respiratory S...
ProAxsis registers European CE Mark for first neutrophil elastase point-of-care test
ProAxsis Ltd today announces that the company has completed the development process for NEATstik®, a n...
Proaxsis